Title: Ebola & Marburg | NIH: National Institute of Allergy and Infectious Diseases
Headings: Ebola & Marburg
Ebola & Marburg
Why Is the Study of Ebola & Marburg a Priority for NIAID?
How Is NIAID Addressing This Critical Topic?
Vaccines
Diagnosis
Treatment
Researching Ebola in Africa
Was This Page Helpful?

Content: How Is NIAID Addressing This Critical Topic? NIAID researchers and NIAID-supported scientists at external institutions are studying many aspects of the Ebola and Marburg viruses and how they cause disease. This includes seeking better ways to diagnose and treat Ebola virus disease and Marburg fevers and using applied research to develop and test vaccines and treatments. To learn about risk factors for Ebola and Marburg, as well as learn current prevention and treatment strategies visit the MedlinePlus Ebola site or the visit the Centers for Disease Control and Prevention Marburgh hemorrhagic fever site . Vaccines
NIAID is supporting the development of multiple Ebola vaccine candidates that are in various stages of development. Ebola vaccines are designed to prevent infection. Read more about Ebola vaccines
Diagnosis
NIAID is supporting the development of improved diagnostics to detect Ebola virus infection, including those that can provide rapid identification and can be deployed at the point of care where Ebola virus outbreaks occur. Read more about Ebola diagnosis
Treatment
NIAID is advancing research on several investigational Ebola treatments in different stages of development, including monoclonal antibodies and antivirals. Read more about Ebola treatment
Researching Ebola in Africa
The 2014-2016 Ebola outbreak in West Africa was the largest recorded in history. As local and international healthcare workers responded to the outbreak, NIAID and the Liberian Ministry of Health established PREVAIL, or the Partnership for Research on Ebola Virus in Liberia.